MedPath

Evaluation the sensitivity and specificity of a novel diagnostic kit for the detection of placental alpha-microglobulin-1 (PAMG-1) in the prediction of preterm birth

Phase 1
Active, not recruiting
Conditions
Preterm birth
PAMG &#45
1 positive
PAMG&#45
1 negative
Registration Number
TCTR20180703002
Lead Sponsor
no
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Active, not recruiting
Sex
Female
Target Recruitment
160
Inclusion Criteria

1. Preterm labour during gesttaional age about 20-36 weeks of gestation.
2. No leakage of amniotic fluid.
3. cervical opening not greater than 3 cm.

Exclusion Criteria

1. Pregnant women less than 18 years old.
2. Pregnant women with leakage of amniotic fluid or bleeding per vagina
3. Pregnant with previous digital examination.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
PAMG1 results until delivery Positive and Negative
Secondary Outcome Measures
NameTimeMethod
Preterm birth until delivery Time of delivery
© Copyright 2025. All Rights Reserved by MedPath